Page last updated: 2024-11-05

nonacosane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nonacosane is a saturated hydrocarbon with the chemical formula C29H60. It is a white, waxy solid that is found in a variety of natural sources, including beeswax, petroleum, and plant waxes. Nonacosane is used in a variety of applications, including as a lubricant, a plasticizer, and a component of cosmetics and pharmaceuticals. It is also used in the production of candles and other products. Nonacosane is not known to have any significant biological activity. It is not readily absorbed by the skin and is not considered to be toxic.'

nonacosane: constituent of Apocynum venetum leaf [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

nonacosane : A straight-chain alkane comprising of 29 carbon atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
ApocynumgenusA plant genus of the family APOCYNACEAE. On rare occasions it is called Milkweed, but should not be confused with true Milkweed (ASCLEPIAS).[MeSH]ApocynaceaeThe dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.[MeSH]
Apocynum venetumspecies[no description available]ApocynaceaeThe dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.[MeSH]

Cross-References

ID SourceID
PubMed CID12409
CHEMBL ID428955
CHEBI ID7613
MeSH IDM0137346

Synonyms (33)

Synonym
n-nonacosane
CHEBI:7613 ,
ch3-[ch2]27-ch3
LMFA11000005
C08384
nonacosane
630-03-5
nonacosane, 99%
DC7C60EC-A78D-4260-BEE6-9249D1D69C33
CHEMBL428955
N0167
hsdb 8359
igl1697bk1 ,
einecs 211-126-2
ai3-36284
unii-igl1697bk1
FT-0632673
AKOS015902539
celidoniol, deoxy-
IGGUPRCHHJZPBS-UHFFFAOYSA-N
DTXSID2060884 ,
mfcd00009356
octacosane, methyl-
nonacosane, analytical standard
dtxcid8043602
ch3-(ch2)27-ch3
nonacosane; celidoniol, deoxy- (7ci); n-nonacosane
Q151038
CS-0032473
n-boc-4-nitro-l-phenylalanine-t-butylester
P50001
AS-56220
HY-N5127

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Moreover, their high human intestinal absorption and bioavailability score along with their classification as non-mutagen in the Ames test makes these compounds more reliable as potent antineurodegenerative drugs."( Computational Analysis of
Das, SK; Hui, PK; Khan, A; Mahanta, S; Mohanta, YK; Roy, N; Sangeet, S; Saravanan, M; Tag, H, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
long-chain alkaneAny alkane having a chain length of at least 13 carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID315606Growth inhibition of human BGC823 cells at 5 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID315609Growth inhibition of human BGC823 cells at 100 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID315608Growth inhibition of human BGC823 cells at 50 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID315607Growth inhibition of human BGC823 cells at 10 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.11)18.7374
1990's4 (22.22)18.2507
2000's4 (22.22)29.6817
2010's7 (38.89)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.98 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index42.91 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.56%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]